ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Lyxor Asset Management Luxembourg SA

Lyxor Asset Management Luxembourg SA (BUN6)

12.2319
-0.0189
(-0.15%)
Closed January 22 4:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
12.2319
Bid
12.2061
Ask
12.2577
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
12.2508
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

BUN6 Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000FU
40000000FU
120000000FU
260000000FU
520000000FU
1560000000FU
2600000000FU

BUN6 - Frequently Asked Questions (FAQ)

What is the current Lyxor Asset Management L... share price?
The current share price of Lyxor Asset Management L... is 12.2319 €
What is the 1 year trading range for Lyxor Asset Management L... share price?
Lyxor Asset Management L... has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PNYPine Technology Holdings Ltd
0.0065 €
(44.44%)
35k
AAHAhlers AG
0.01 €
(42.86%)
12k
38ERekor Systems Inc
1.984 €
(32.09%)
39.11k
L7C2Windfall Geotek Inc
0.011 €
(29.41%)
11.72k
9AJ1Altiplano Metals Inc
0.0438 €
(28.82%)
13.61k
432Arbor Metals Corp
0.318 €
(-43.82%)
2.11M
PQWNPacific Ridge Exploration Ltd
0.007 €
(-41.67%)
36.12k
BDDOrdinary Shares
0.0034 €
(-41.38%)
10.6k
R1EAEV Resources Ltd
0.0012 €
(-40.01%)
6.08k
E3O1Nexoptic Technology Corp
0.0095 €
(-38.71%)
12.79k
D7GNel ASA
0.1905 €
(-1.55%)
4.93M
PF8European Lithium Limited
0.0408 €
(-8.11%)
3.57M
RQ0DWave Quantum Inc
6.016 €
(-0.76%)
3.27M
SHA0Schaeffler AG
3.96 €
(-9.02%)
2.31M
24YBrainchip Holdings Ltd
0.2318 €
(14.19%)
2.19M

Discussion

View Full Feed
boarddork boarddork 5 minutes ago
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 5 minutes ago
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 6 minutes ago
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 7 minutes ago
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 8 minutes ago
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 8 minutes ago
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 11 minutes ago
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 11 minutes ago
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 11 minutes ago
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 12 minutes ago
Whats 305
RNVA
theorysuit theorysuit 14 minutes ago
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 14 minutes ago
Yes I bet it 2x better then before strap in stock-nuts
CLHI
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 14 minutes ago
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days. Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s adva
AVXL
GUNSMOKE GUNSMOKE 15 minutes ago
https://www.otcmarkets.com/filing/html?id=18121280&guid=sJ0-kqxrs0Hhh3h
ASST
band aid band aid 15 minutes ago
Bobby, he or she is saying that this is a PIG. I wish you good luck here and I hope you hit it out of the park. As for me I took a huge pounding on this trash but still hold a small position just in case the sky falls out of the universe and this PIG could figure out a way to sell some of their jun
BIEL
glens0 glens0 16 minutes ago
CTOR Not to many shares left in the market. Should go up real fast when good news comes out.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
NoMoDo NoMoDo 17 minutes ago
Done. He is an amazing boy. Nuclear engineer.
HMBL
Acme Investments Acme Investments 17 minutes ago
👇 When he comes through it will be something else for you clowns to talk about!! Sitting around counting days is Sad!!
BCAP
Whalatane Whalatane 17 minutes ago
Recent Open Market purchases by the Chairman of the Board ...David Mott
On December 19, 2024, Mott purchased 213,300 shares at an average price of $4.6722, for a total amount of $996,58034.
On November 13, 2024, he bought 215,868 shares at an average price of $4.6167, totaling $996,59
ARDX

Your Recent History

Delayed Upgrade Clock